美国 · 股市与财经 · Forbes
Reimbursement For Multi-Cancer Early Detection Tests Faces Uncertainty
Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.
在 Forbes 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.forbes.com)




